“…It has been shown that UCB‐SC treatment plays a neural‐restorative and neural‐regenerative role in premature brain injuries (Sun & Kurtzberg, ) (Figure ). Some UCB‐SCs likely differentiate into “replacement” glial cells and neurons and integrate into the host brain where they play a role in re‐myelination (Sato et al, ; Shen et al, ). In addition, UCB‐SCs might enhance blood vessel regeneration (Kourembanas, ), and an increasing number of studies have indicated that UCB‐SCs migrating to the site of brain injury might provide restorative and neuroprotective factors or endogenous cell signals to injured host neural cells via the paracrine activity of immune factors, anti‐inflammatory cytokines such as IL‐8 and IL‐10 (Nazmi et al, ; Xia et al, ), and neurotrophic factors such as neurotrophin‐3/4, brain‐derived neurotrophic factors, glial‐derived neurotrophic factor, vascular endothelial growth factor, hepatocyte growth factor, and insulin‐like growth factor‐1, which support neuronal migration, proliferation, and differentiation and promote angiogenesis (Bennet et al, ; Drobyshevsky et al, ; Geisler, Dinse, Neuhoff, Kreikemeier, & Meier, ; Hellstrom et al, ; Rosenkranz & Meier, ).…”